Heparin cofactor (HC ) specifically inhibits thrombin action at the site of vascular wall injury. We encountered a congenital HC deficiency patient with advanced multiple atherosclerotic lesions. This patient led us to conduct clinical studies to examine the role of HC against atherosclerosis. We found that the incidence of in-stent restenosis after percutaneous coronary intervention, severity of carotid atherosclerosis and prevalence of peripheral arterial disease are inversely associated with plasma HC activity. In order to clarify the vascular protective action of HC , we generated HCdeficient mice by gene targeting. In contrast to a previous study, HC / 
Among the 4 members of the family of PARs, PAR-1 is known as the most important thrombin receptor in vascular remodeling. Under physiological conditions, PAR-1 is mainly expressed in endothelial cells and participates in the regulation of vascular tone, mostly by inducing endothelium-dependent relaxation. In VSMCs, PAR-1 mediates contraction, migration, proliferation, hypertrophy and production of the extracellular matrix and contributes to the development of vascular lesions such as atherosclerosis 3) . Although approximately half of PAR-1-deficient mice are embryonically lethal 4) , mice that survive manifest diminished neointimal hyperplasia after arterial injury compared with that in wild-type mice
Introduction
Thrombin is a multi-potential serine protease generated at the site of vascular injury. Thrombin transforms fibrinogen into fibrin, accelerates platelet aggregation and elicits many biological effects on a variety of cell types, including endothelial cells, vascular smooth muscle cells (VSMCs), monocytes, lymphocytes and fibroblasts 1) . Cellular effects of thrombin are mediated by protease-activated receptors (PARs), members of the G protein-coupled receptor family 2) . tion of thrombin action is effective for treatment and prevention of cardiovascular diseases. Since heparin cofactor (HC ) is known to be an endogenous thrombin inhibitor in the vascular wall, this review focuses on the role of HC in protection against vascular remodeling and atherosclerosis via its inhibitory effect on thrombin action in the vascular wall.
Biochemical Features of Heparin Cofactor
Enhanced thrombin action at sites of vascular wall injury is efficiently inhibited by HC . HC , as well as antithrombin (AT), is a serine protease inhibitor (serpin) with a molecular weight of 65.6 kDa. HC is synthesized by hepatocytes and secreted into the blood stream at a concentration of about 1.0 mol/L 9) , and it is distributed in the intima and media of atheroscelotic lesions as well as the walls of normal arteries. Although AT targets several coagulation-related proteases, including thrombin, factor Xa and factor IXa, HC inactivates only thrombin without affecting other proteases involved in the blood coagulation cascade 10) . HC has the unique ability to inhibit thrombin action by the formation of a bimolecular complex with dermatan sulfate (DS), a glycosaminoglycan, which is synthesized and secreted by vascular smooth muscle cells and fibroblasts and is deposited in the matrix of vascular intima and media ( Fig. 1) 9, [11] [12] [13] [14] [15] [16] . AT inhibits thrombin action and elicits an anti-coagulatory effect at the surface of the vascular wall, whereas HC can most efficiently act in the intima and media of the vascular wall to protect them from the actions of thrombin on vascular remodeling.
Advanced Multiple Atherosclerotic Lesions in an Elderly Japanese Female with Congenital HC Deficiency
Congenital HC deficiency is inherited in an autosomal dominant fashion and is classified into quantitative deficiency type (type ) and qualitative deficiency type (type ). Since several families with HC deficiency associated with thrombosis have been reported [17] [18] [19] [20] , HC deficiency has been thought to be a low to modest clinical risk factor for venous thrombosis, as is plasminogen deficiency. In 2001, we reported a 66-year-old female with type congenital HC deficiency who manifested multiple atherosclerotic lesions, including multiple coronary artery stenosis, bilateral carotid stenosis, right renal artery stenosis and a huge abdominal aortic aneurysm (Fig. 2) 
21)
. Although she did not have any other classical cardiovascular risk factors except mild essential hypertension, her plasma HC activity was 41% and plasma HC antigen was 44%. Her elder brother, who also had congenital HC deficiency, had a history of stroke at the age of 70 years. In addition to the above patients with congenital HC deficiency, Kondo et al. reported a Japanese patient with type HC deficiency who suffered from angina pectoris and coronary artery disease 22) . This raised the possibility that because of impaired thrombin inactivation, HC deficiency causes acceleration of the development of atherosclerosis in elderly individuals who have injured vascular walls.
Clinical Studies on HC and Vascular Remodeling

Coronary Artery Disease
In order to test the possibility that HC deficiency accelerates atherosclerotic lesions in the elderly, we first assessed the association between plasma HC activity and coronary artery disease in Japanese elderly subjects 23) . Sequential coronary arteries (n 166) with bare-metal stent implantation in 134 patients were evaluated before, immediately after, and at 6 months After binding with dermatan sulfate (DS) and HC , translocation of the N-terminalacidic domain of HC occurrs and the structural change enables interaction with theN-terminal acidic domain of HC and anion-binding exosite (Exo ) of thrombin. DS also binds to exosite (Exo ) of thrombin, forming a bridge between HC and thrombin. Modified from articles by Tollefsen 15, 16) . after percutaneous coronary intervention (PCI). Patients with high plasma HC activity ( 110%) showed low percent diameter stenosis at follow-up compared with that in patients with normal plasma HC activity ( 80% and 110%) or low plasma HC activity ( 80%). In-stent restenosis rate in the high-HC group was also lower than that in the low-HC group, and multivariate analysis demonstrated that a high level of plasma HC activity is an independent protective factor against angiographic restenosis ( Fig. 3) 
23)
. Huang and colleagues examined the relationship between plasma HC activity and cardiovascular prognosis in patients with acute myocardial infarction (AMI) 24) . In their study, 110 consecutive patients (aged 63 11 years) with AMI were followed up for 42 12 months. The patients were divided into three groups: a high-HC group ( 122%), a normal-HC group ( 98% and 122%), and a low-HC group ( 98%). The high-HC group had a tendency toward reduced major adverse cardiovascular events (MACE), including rehospitalization because of unstable angina, nonfatal MI, revascularization with either PCI or coronary artery bypass grafting (CABG), ischemic stroke, and Multivariate analysis demonstrated that plasma HC activity is independently and inversely associated with angiographic in-stent restenosis after PCI. Odds ratio of HC represents a value of 1% increase in plasma HC activity. AT: antithrombin, HC : heparin cofactor , MLD: minimal lumen diameter Modified from the article by Takamori et al. 23) .
cardiovascular death, compared with other groups. Multivariate regression analysis including all patients showed that plasma HC activity was an independent predictor of future MACE.
Carotid Atherosclerosis
Since our HC -deficient patient manifested carotid atherosclerosis and her elder brother had a history of stroke, we speculated that HC also has a protective role in carotid atherosclerosis and cerebrovascular events. In order to clarify the relationship between plasma HC activity and severity of carotid atherosclerosis, we measured plasma HC activity and performed carotid arterial ultrasonography in 306 Japanese individuals (154 men and 152 women) over 40 years of age (68.9 11.1 years, mean SD) 25) . In that study, the thickness of carotid plaque was found to be inversely correlated with plasma HC activity (Fig. 4) 25) . Multiple regression analysis revealed that plasma HC activity and HDL cholesterol independently contributed to the suppression of intima-media thickening and that the antiatherogenic contribution of HC activity was stronger than that of HDL cholesterol 25) .
Peripheral Arterial Disease
Patients with impaired blood flow to the extremities as a consequence of peripheral arterial disease (PAD) may present with typical ischemic pain of muscle, atypical pain or no symptoms. The presence of PAD is a strong predictor of future cardiovascular and cerebrovascular events, such as myocardial infarction, stroke and death [26] [27] [28] [29] . Because these vascular risks are already increased considerably in patients with asymptomatic PAD and are further increased in PAD patients with intermittent claudication, the clinical importance of early diagnosis during the subclinical stage as well as subsequent management of vascular risks has been noted 30) . Risk factors for development of peripheral arterial atherosclerosis are similar to those for the development of coronary atherosclerosis, such as diabetes mellitus, hyperlipidemia, cigarette smoking and hypertension. Although an endogenous protective factor against the progression of PAD has not been elucidated, we hypothesized that HC can attenuate the development of PAD. In order to clarify this issue, plasma HC activity and ankle brachial pressure index (ABI) were determined in 494 Japanese elderly subjects with cardiovascular risk factors 31) . Diagnosis of PAD was made by ABI below 0.9, and 62 subjects were diagnosed as having PAD. Multivariate logistic regression analysis showed that age, current smoking and the presence of diabetes mellitus were independent and progressive determinants of PAD (Fig. 5) . In contrast, HC was an independent protective factor against PAD (Fig. 5) 
31)
. In order to elucidate the protective effect of HC in patients with PAD who underwent femoropopliteal stent implantation after initial failure of plain balloon angioplasty due to significant residual stenosis ( 30% lumen diameter reduction) or flow-limiting dissection, Schillinger et al. studied An inverse relation between plasma HC activity and carotid artery Max-IMT was observed. The scatter plots were adjusted for age and sex. Modified from the article by Aihara et al. 25) .
Fig. 5. Multivariate regression analysis for determinants of PAD.
Multivariate analysis demonstrated that plasma HC activity is independently and inversely associated with prevalence of PAD. Odds ratio of HC represents a value of 1% increase in plasma HCII activity. Modified from the article by Aihara et al. 31) .
63 consecutive patients with PAD 32) . Plasma HC activity was measured before stenting and the patients were followed for a median 10 months (interquartile range: 6 to 17 months) for the occurrence of first in-stent restenosis. Cumulative freedom from restenosis at 6 and 12 months in patients with low HC activity ( 100%, lower tertile) was 84% and 35%, respectively, whereas 93% and 72% in patients with high HC activity ( 100%, higher tertile). After adjustment for the material of the implanted stents and other cardiovascular risk factors, high HC activity was found to exert a protective effect against instent restenosis in the femoropopliteal artery. Taken together, the results indicated that plasma HC activity is a predictor of the development of PAD as well as restenosis after femoropopliteal stent implantation.
Endothelial Function and Future Cardiovascular Events
The vasodilator function of the vascular endothelium serves as an indicator of atherosclerotic risk. A healthy endothelium is antiatherogenic through favorable paracrine effects on vasodilation, inhibition of leukocyte adhesion, platelet aggregation/coagulation, and promotion of healing via progenitor cells 33) . Recently, measurement of brachial artery flow-mediated vasodilation (FMD) has become the most widely used method for assessing endothelial function, and evidence of a relationship between FMD and cardiovascular events has accumulated 34, 35) . Huang et al. evaluated the clinical significance of plasma HC activity in relation to FMD and the incidence of cardiovascular events 36) . In that study, 199 patients aged 63 14 years were enrolled and followed up for a median period of 24 months, and endothelial function was assessed using brachial ultrasonography to determine FMD. Cox regression analyses were conducted for the enrolled subjects, with cardiovascular events being defined as MI, PCI, CABG, ischemic stroke, and peripheral artery revascularization. Multivariate analysis showed that age and high-sensitive CRP were inversely correlated with FMD and that plasma HC activity was positively correlated with FMD. Kaplan-Meier and Cox regression analyses demonstrated that reduced plasma HC activity can predict a high incidence of future cardiovascular events.
Basic Studies Using Cultured Cells on HC and Vascular Remodeling
Hayakawa et al. induced the expression of HC in cultured human fibroblasts and in vascular smooth muscle cells using adenovirus-mediated gene transfer. The gene transfer-induced expression of HC inhibited thrombin-induced interleukin-6 (IL-6) release from fibroblasts and from vascular smooth muscle cells 37) . Since IL-6, an inflammatory cytokine, has a pivotal role in extracellular matrix deposition and reorganization leading to atherosclerosis 38, 39) , HC may Wire-injured femoral arteries in HC / Tokushima mice revealed prominent neointimal hyperplasia and a high incidence of arterial occlusion due to thrombosis. Those abnormalities were ameliorated by human purified HC protein supplementation. Modified from the article by Aihara et al. 42) . have a protective role against thrombin-induced vascular remodeling through inhibition of IL-6 production in fibroblasts and vascular smooth muscle cells.
Studies Using HC -Deficient Mice on Vascular Remodeling
Generation and Characterization of HC -Deficient
Mice Kamp and Ragg showed that the genomic structure of murine and human HC consists of 5 exons that are interrupted by 4 introns 40) . In 2002, He et al. reported the generation of homozygous HC -deficient mice with deletion of 2 kb of the murine HC gene, which encodes the N-terminal half of the protein, including thrombin and dermatan sulfate binding sites 41) . HC / offspring were obtained at close to the expected Mendelian frequency by mating male and female HC / mice (HC / St. Louis mice). Although HC -deficient mice were indistinguishable from their wild-type littermates in weight and survival and did not have spontaneous thrombosis or other morphological abnormalities 41) , the time to thrombotic occlusion of the carotid artery after photochemically induced endothelial cell injury was significantly shorter in HC / mice 41) . The shortened occlusion time in HC / mice was corrected by intravenous infusion of purified human HC protein 41) . In 2007, we independently generated and reported HC -deficient mice. Unexpectedly, mice with homozygous deletion of HC exhibited embryonic lethality after careful backcrossing for 10 generations with C57BL/6J strain 42) . We examined murine karyotypes by chromosome analysis and accuracy of homologous recombination of the targeting vector by Southern blot analysis and FISH analysis in our HC / mice (HC / Tokushima) 42) . As a result, we confirmed the absence of truncated HC transcripts and noninterference for mRNA levels of neighboring .
genes around the HC genome after HC targeting vector introduction in HC / Tokushima mice 42) . Since there is a strain difference between ES cells and screened genome libraries in HC / St. Louis mice and HC / Tokushima mice, the discrepant results appeared to be due to a minor strain-dependent difference in genetic background even after backcrossing for 10 generations. 42) . In addition, markedly broader PAR-1 expression was observed in cuff-injured HC / Tokushima mice than in cuff-injured HC / mice along with the phenotype of enhanced vascular remodeling 42) . Moreover, wire-injured femoral arteries in HC / Tokushima mice revealed marked neointimal hyperplasia and a high intima-to-media ratio compared with HC / mice (Fig. 6) . Wire injury also caused a higher incidence (20%) of arterial occlusion due to thrombosis in HC / Tokushima mice than in HC / mice (10%) (Fig. 6) 42)
Enhanced Vascular Remodeling in HC -
. Since we found enhanced platelet aggregation in HC / Tokushima mice, activation of PARs due to reduced HC activity in platelets may be associated with increased thrombogenicity. All of those abnormalities were ameliorated by human purified HC protein supplementation 42) ( Fig. 6) . Vicente et al. evaluated neointimal formation in HC / St. Louis mice and HC / mice 3 weeks after mechanical dilation of the common carotid artery using a beaded probe 16, 43) . . Histological findings revealed that the atherosclerotic plaque area was significantly increased in the aortic root of HC / (Tokushima) ApoE / mice compared to HC / ApoE / mice (Fig. 7) . In addition, lipid deposition, PAR-1-positive cells and superoxide production in the plaques were more prominent in the aortic root of HC / (Tokushima) ApoE / mice than HC / ApoE / mice (Fig. 7) 42)
. Vicente et al. also generated mice that were deficient in both HC and ApoE gene and investigated the vascular phenotypes in these mice 16, 43) . In the ApoE-null background, atherosclerotic plaque areas in the aortic arch were significantly greater in HC / (St. Louis) mice than in HC / mice 43) .
Summary and Conclusions
Clinical studies have shown that plasma HC activity is inversely associated with the incidence of in-stent restenosis after PCI, severity of carotid atherosclerosis, prevalence of PAD, endothelial dysfunction and future cardiovascular events. Studies using HCdeficient mice have shown that HC is required for fetal development in a mouse line and that HC has protective roles against thrombus formation and vascular remodeling induced by mechanical vascular injury and/or serum lipid abnormality; therefore, HC is a novel predictive marker and a therapeutic target against atherothrombosis. A conceptual diagram of the antiatherogenic action of HC at the vascular wall as presented and overviewed in this review is shown in Fig. 8 .
